Long-Term Safety and Efficacy of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 52-Week, Multicenter, Open-Label Extension Study

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2021.0058 ◽

2021 ◽

Author(s):

Takuya Saito ◽

Yohei Hyodo ◽

Reiko Sakaguchi ◽

Hiroshi Nakamura ◽

Jun Ishigooka

Keyword(s):

Extension Study ◽

Open Label ◽

Oral Tablet ◽

Safety And Efficacy ◽

Open Label Extension

Download Full-text

32.7 Long-Term Safety and Efficacy of Blonanserin Oral Tablet (DSP-5423) in Adolescents With Schizophrenia: A 52-Week, Multicenter, Open-Label, Extension Study

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2021.09.268 ◽

2021 ◽

Vol 60 (10) ◽

pp. S216

Author(s):

Takuya Saito ◽

Hiroshi Nakamura ◽

Jun Ishigooka

Keyword(s):

Extension Study ◽

Open Label ◽

Oral Tablet ◽

Safety And Efficacy ◽

Open Label Extension

Download Full-text

103. Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis: 5-Year Results from a 52-Week Randomized Controlled Trial and Open-Label Extension Study

Rheumatology ◽

10.1093/rheumatology/keu101.024 ◽

2014 ◽

Vol 53 (suppl_1) ◽

pp. i96-i96 ◽

Cited By ~ 1

Author(s):

Edward Keystone ◽

Robert Landewé ◽

Ronald van Vollenhoven ◽

Bernard Combe ◽

Vibeke Strand ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Randomized Controlled Trial ◽

Controlled Trial ◽

Certolizumab Pegol ◽

Extension Study ◽

Open Label ◽

Safety And Efficacy ◽

Randomized Controlled ◽

Open Label Extension

Download Full-text

P036 LONG-TERM SAFETY AND EFFICACY OF THE ANTI-MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MADCAM-1) ANTIBODY SHP647 IN ULCERATIVE COLITIS: AN OPEN-LABEL EXTENSION STUDY (TURANDOT II)

Gastroenterology ◽

10.1053/j.gastro.2019.01.088 ◽

2019 ◽

Vol 156 (3) ◽

pp. S25-S26

Author(s):

Walter Reinisch ◽

William J. Sandborn ◽

Silvio Danese ◽

Xavier Hébuterne ◽

Bruce Salzberg ◽

...

Keyword(s):

Ulcerative Colitis ◽

Cell Adhesion ◽

Adhesion Molecule ◽

Cell Adhesion Molecule ◽

Extension Study ◽

Open Label ◽

Safety And Efficacy ◽

Open Label Extension ◽

Cell Adhesion Molecule 1

Download Full-text

Long-term safety and efficacy of lumacaftor–ivacaftor therapy in children aged 6–11 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a phase 3, open-label, extension study

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(20)30517-8 ◽

2021 ◽

Author(s):

Mark A Chilvers ◽

Jane C Davies ◽

Carlos Milla ◽

Simon Tian ◽

Zifei Han ◽

...

Keyword(s):

Cystic Fibrosis ◽

Extension Study ◽

Open Label ◽

Phase 3 ◽

Safety And Efficacy ◽

Open Label Extension

Download Full-text

MP31-01 LONG-TERM SAFETY AND EFFICACY OF SER120 1.5 MCG IN PATIENTS WITH NOCTURIA: RESULTS FROM A 2-YEAR OPEN-LABEL EXTENSION STUDY

The Journal of Urology ◽

10.1016/j.juro.2017.02.955 ◽

2017 ◽

Vol 197 (4S) ◽

Author(s):

Scott MacDiarmid ◽

J.P. Nicandro ◽

Maria Cheng ◽

Steven Abrams ◽

Seymour Fein ◽

...

Keyword(s):

Extension Study ◽

Open Label ◽

Safety And Efficacy ◽

Open Label Extension

Download Full-text

Long-Term Safety and Efficacy of a Once-Daily Formulation of Alfuzosin 10 mg in Patients with Symptomatic Benign Prostatic Hyperplasia: Open-Label Extension Study

European Urology ◽

10.1016/s0302-2838(01)00016-1 ◽

2002 ◽

Vol 41 (1) ◽

pp. 54-61 ◽

Cited By ~ 43

Author(s):

P van Kerrebroeck ◽

A Jardin ◽

P van Cangh ◽

K.U Laval

Keyword(s):

Benign Prostatic Hyperplasia ◽

Prostatic Hyperplasia ◽

Extension Study ◽

Open Label ◽

Symptomatic Benign Prostatic Hyperplasia ◽

Once Daily ◽

Safety And Efficacy ◽

Open Label Extension

Download Full-text

Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(21)00322-2 ◽

2021 ◽

Author(s):

Michael E Wechsler ◽

Linda B Ford ◽

Jorge F Maspero ◽

Ian D Pavord ◽

Alberto Papi ◽

...

Keyword(s):

Severe Asthma ◽

Extension Study ◽

Open Label ◽

Safety And Efficacy ◽

Open Label Extension

Download Full-text

Long-term safety and efficacy of ABT-874 for the treatment of moderate to severe psoriasis: Interim analysis from an open-label extension study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2010.09.605 ◽

2011 ◽

Vol 64 (2) ◽

pp. AB148 ◽

Cited By ~ 3

Keyword(s):

Interim Analysis ◽

Severe Psoriasis ◽

Extension Study ◽

Open Label ◽

Safety And Efficacy ◽

Open Label Extension

Download Full-text

A Long-Term Open-Label Extension Study Assessing Cognition and Behavior, Tolerability, Safety, and Efficacy of Adjunctive Levetiracetam in Children Aged 4 to 16 Years With Partial-Onset Seizures

Journal of Child Neurology ◽

10.1177/0883073811417183 ◽

2011 ◽

Vol 27 (1) ◽

pp. 80-89 ◽

Cited By ~ 34

Author(s):

Jimmy Schiemann-Delgado ◽

Haichen Yang ◽

Christine de la Loge ◽

Tracy J. Stalvey ◽

John Jones ◽

...

Keyword(s):

Extension Study ◽

Open Label ◽

Safety And Efficacy ◽

Open Label Extension ◽

And Behavior

Download Full-text

Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(20)30510-5 ◽

2021 ◽

Author(s):

Patrick A Flume ◽

Reta Fischer Biner ◽

Damian G Downey ◽

Cynthia Brown ◽

Manu Jain ◽

...

Keyword(s):

Cystic Fibrosis ◽

Extension Study ◽

Open Label ◽

Safety And Efficacy ◽

Open Label Extension

Download Full-text